NCT00867737View on ClinicalTrials.gov

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

PHASE4UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
Asthma
Interventions
DRUG

Advair HFA MDI 115/21

Two puffs from MDI twice daily for 4 weeks

DRUG

Symbicort 160/4.5 pMDI

"Symbicort 160/4.5 pMDI~Two puffs from MDI twice daily for 4 weeks"

Trial Locations (1)

79925

RECRUITING

Allergy and Asthma Center of El Paso, El Paso

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Allergy and Asthma Center of El Paso

OTHER